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Cationic amino acid (CAA) transport is brought about by two families
of proteins that are found in various tissues: Cat (CAA transporter),
referred to as system y⫹, and Bat [broad-scope amino acid (AA)
transporter], which comprises systems b0,⫹, B0,⫹, and y⫹L. CAA
traverse the blood-brain barrier (BBB), but experiments done in vivo
have only been able to examine the BBB from the luminal (bloodfacing) side. In the present study, plasma membranes isolated from
bovine brain microvessels were used to identify and characterize the
CAA transporter(s) on both sides of the BBB. From these studies, it
was concluded that system y⫹ was the only transporter present, with
a prevalence of activity on the abluminal membrane. System y⫹ was
voltage dependent and had a Km of 470 ⫾ 106 M (SE) for lysine, a
Ki of 34 M for arginine, and a Ki of 290 M for ornithine. In the
presence of Na⫹, system y⫹ was inhibited by several essential neutral
AAs. The Ki values were 3–10 times the plasma concentrations,
suggesting that system y⫹ was not as important a point of access for
these AAs as system L1. Several small nonessential AAs (serine,
glutamine, alanine,and glycine) inhibited system y⫹ with Ki values
similar to their plasma concentrations, suggesting that system y⫹ may
account for the permeability of the BBB to these AAs. System y⫹ may
be important in the provision of arginine for NO synthesis. Real-time
PCR and Western blotting techniques established the presence of the
three known nitric oxide synthases in cerebral endothelial cells:
NOS-1 (neuronal), NOS-2 (inducible), and NOS-3 (endothelial).
These results confirm that system y⫹ is the only CAA transporter in
the BBB and suggest that NO can be produced in brain endothelial
cells.
amino acid active transport; brain capillaries; endothelial cells; essential amino acids; nonessential amino acids; polarity
THE BLOOD-BRAIN BARRIER (BBB) surrounds almost the entire
central nervous system and separates the brain from the circulation. Cerebral capillary endothelial cells, which have a larger
number of tight junctions than what is found in other continuous capillaries, form the BBB. These tight junctions restrain
paracellular movement and divide the membranes of the endothelial cells into two distinct sides, luminal (blood side) and
abluminal (brain side), thereby creating polarity (50, 51).
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Different populations of both lipids and intrinsic proteins (e.g.,
transporters) exist on the luminal and abluminal sides (3, 4,
46). Therefore, hydrophilic nutrients, such as amino acids
(AAs), must pass two sheaths of membrane, the combined
characteristics of which determine which molecules traverse
the barrier and how quickly.
Studies of AA transport across the BBB in vivo and in vitro
showed the BBB to be polarized with respect to AAs. The
facilitative transport system L1 that transports large neutral
amino acids (LNAA) exists on both the luminal and abluminal
membranes (38, 39). The system XAG⫺ that transports glutamate exists only on the luminal membrane, as does the system
N that transports glutamine (26). However, no Na⫹-dependent
systems have been found on the luminal membrane (1, 9, 32,
40, 41, 44). On the other hand, five transport systems have been
found to date that are located on the abluminal membrane.
These transporters include systems A, ASC, and N, which
collectively transport neutral amino acids (NAA) (31), and
Na⫹-LNAA, which transports LNAA (primarily essential). In
addition there are at least three members of system EAAT
(excitatory AA transporter) that transport acidic (or anionic)
amino acids (AAA). These Na⫹-dependent systems may couple the Na⫹ gradient that exists between the extracellular fluid
(ECF) and endothelial cells to actively remove AAs from the
brain’s ECF. The organization of the Na⫹-dependent transporters on the abluminal membrane and facilitative transporters on
the luminal membrane of the BBB explains why the concentrations of all AAs (except glutamine) are much lower in the
ECF of brain than in the plasma; ECF concentrations are
⬃10% of the plasma values (42).
The situation for cationic amino acids (CAA; lysine, arginine, and ornithine) is less well known. The concentration of
CAA in ECF is 10 –30% that of plasma. A facilitative transporter of CAA exists, at least on the luminal side (32), and
experiments in vivo indicate system y⫹ as the primary mechanism for CAA transport (43). Although it has been proposed
that system y⫹ exists on both sides, this has not been measured
directly. The other potential transporters of CAA include
system y⫹L, a broad-scope AA transporter that was first
identified in human erythrocytes (16, 17, 34); system B0,⫹, a
Na⫹-dependent carrier that carries CAA (as well as NAA,
although with less affinity) (53); and system b0,⫹, a facilitative
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transporter (53–55). Whether any other system besides y⫹ is
present on the BBB has not been evaluated.
The lower concentration of CAA in ECF could be explained
by brain metabolism or by the presence of a Na⫹-dependent
transport system on the abluminal membranes. Therefore, the
first objective was to study CAA transport using isolated
luminal and abluminal plasma membrane vesicles from bovine
BBB to identify and characterize the transporter(s) responsible.
One of the CAA, arginine, is the precursor of nitric oxide
(NO). NO is a diffusible gas, originally called endotheliumderived relaxing factor, that regulates numerous physiological
actions, including smooth muscle contraction, blood flow, and
pressure (35). NO also acts as a signal to regulate gene
expression, apoptosis, cell cycle, and differentiation (20). The
biosynthesis of this physiological messenger requires L-arginine and O2 for the NO synthase (NOS)-catalyzed reaction.
Three isoforms of NOS have been identified: neuronal (NOS1), inducible (NOS-2), and endothelial (NOS-3) (61). Endothelial cells do not have the ability to synthesize arginine de
novo (60). Therefore, endothelial cells must rely on an external
source of arginine; it seems that the availability of arginine is
the determining factor in NO production by endothelial cells
(60, 61).
Which forms of NOS exist in the BBB has not been studied.
Thus the second objective of this study was to examine the
presence of the enzymes required for NO production within the
endothelial cells of brain.
MATERIALS AND METHODS

Materials. L-[14C]lysine (290 mCi/mmol) was purchased from American Radiolabeled Chemicals (St. Louis, MO), AAs, collagenase type IA,
methyl-amino isobutyric acid (MeAIB), and 2-aminobicyclo(2.2.1)heptane2-carboxylic acid (BCH) from Sigma (St. Louis, MO), and the Bio-Rad
protein assay from Bio-Rad Laboratories (Hercules, CA).
Animals. Fresh bovine brains were bought from Aurora Meat
Packing (North Aurora, IL). The cows were killed for food under US
Department of Agriculture supervision, and the meat was sold for
human consumption.
Preparation of membrane vesicles. Membrane vesicles from brain
endothelial cells were prepared as previously described (38). Briefly,
isolated microvessels from bovine cerebral cortices were obtained as
described by Pardridge et al. (36). With the exception of one experiment wherein NOSs were studied, the microvessels were digested
with collagenase type IA to remove the basement membrane, pericytes, and glial fragments. The refined microvessels were homogenized to release endothelial cell membranes containing both luminal
and abluminal domains. In one experiment where the relative activity
of CAA transport was to be determined, the membranes were further
separated into luminal and abluminal membranes as previously described (38). The luminal vesicles were 90% pure, whereas the
abluminal membranes were 80% pure. The assessment of purity was
as described by Sánchez del Pino et al. (37, 39) using ␥-glutamyl
transpeptidase as a luminal membrane marker and MeAIB transport
(system A) activity as an abluminal marker. The vesicles were stored
at ⫺70°C until they were used.
RNA extraction and PCR analysis. Total RNA was isolated from
bovine microvessels (both treated with collagenase type IA and
untreated) using the TRIzol reagent (Invitrogen Life Technologies,
Frederick, MD). Reverse transcription (RT) and polymerase chain
reaction (PCR) were performed in one step using the TTh DNA
polymerase kit (Roche Diagnostics). The mRNA expression was
studied by real-time PCR (iCycler iQ real-time PCR detection system), and specific oligonucleotides for NOS-1, 5⬘-TGGTGGTGGATAJP-Endocrinol Metab • VOL
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GCTTGTTGT-3⬘ and 5⬘-AGTGGTTTCCTGGTGAGGTG-3⬘; NOS-2,
5⬘-CTCCAGAATCCCTGAGCAAG-3⬘ and 5⬘-TTTTGGGGTTCATGATGGAT-3⬘; NOS-3, 5⬘-CCAGCTCAAGACTGGAGACC-3⬘ and
5⬘-TCAATGTCATGCAGCCTCTC-3⬘; and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as an internal control, 5⬘-GGGTCATCATCTCTGCACCT-3⬘ and 5⬘-GGTCATAAGTCCCTCCACGA-3⬘;
were used. The mRNA detection was carried out by measuring the
binding of the fluorescent dye SYBR Green I to double-stranded
DNA. The threshold cycle (CT) was determined, and then the relative
gene expression was expressed as follows: fold change ⫽ 2⫺⌬(⌬CT),
where ⌬CT ⫽ CT (target) ⫺ CT (housekeeping) and ⌬(⌬CT) ⫽ ⌬CT
(treated) ⫺ ⌬CT (control).
For semiquantitative PCR, the resulting PCR products were separated by electrophoresis in a 1.2% agarose gel in Tris-borate-EDTA
(90 mM Tris, 90 mM boric acid, 2 mM EDTA, pH 8.0) and stained
with ethidium bromide. The expected sizes for the PCR products were
176 (GAPDH), 221 (NOS-1), 171 (NOS-2), and 156 bp (NOS-3).
Protein extraction and immunoblotting. The “digested” and “undigested” cow capillaries (0.1 g) were homogenized (Ultra-Turrax;
IKA-Werke, Staufen, Germany) in 1 ml of extraction buffer (20 mM
HEPES, pH 7.9, 20% glycerol, 250 mM KCl, 2 mM MgCl2, 0.2 mM
EDTA, 0.5 mM DTT, 1 mM PMSF, 5 mM NaF, 0.5 mM Na3VO4, and
0.1% Triton X-100) in the presence of protease inhibitors (5 l/ml of
protease inhibitor cocktail from Sigma). The resulting homogenate
was centrifuged at 20,000 g for 20 min at 4°C, and supernatants were
normalized for protein concentration using the bicinchoninic acid
protein assay reagent (Pierce Chemical, Rockford, IL).
Equal amounts of protein (20 g) were then boiled in sample buffer
for 5 min and separated by SDS-PAGE. After electrophoresis, the
proteins were transferred to 0.45-m pore-size nitrocellulose. The
procedure was the same for all antibodies. The membranes were
incubated in blocking solution (5% wt/vol nonfat dry milk with 0.05%
vol/vol Tween-20) for 1 h at room temperature. This was followed by
three washes with Tween-Tris-buffered saline (TTBS; 25 mM
Tris 䡠 HCl, pH 7.5, 0.15 M NaCl, and 0.1% vol/vol Tween-20). Next,
blots were incubated with primary antibodies to NOS-1, NOS-2, and
NOS-3. Rabbit polyclonal antibodies were from Affinity Bioreagents,
and mouse monoclonal ␣-tubulin was from Santa Cruz Biotech (Santa
Cruz, CA) in TTBS for 1 h at room temperature. Blots were washed
again with TTBS and incubated with the secondary antibody conjugated to horseradish peroxidase (Santa Cruz Biotech) for 1 h at room
temperature. Finally, blots were washed with TTBS, and antibody was
detected with luminol reagent (Supersignal West Pico; Pierce Chemical).
Measurement of transport rates. Experiments were performed by a
rapid filtration method (39). Membrane vesicles were thawed, centrifuged at 37,500 g for 25 min at 4°C, and suspended in storage buffer
(290 mM mannitol, 10 mM HEPES, pH 7.4). Vesicles were allowed
to equilibrate overnight at 4°C. The final concentration of protein was
between 2.5 and 5 g protein/l. The vesicle suspensions were
divided into 5-l aliquots that were preincubated at 37°C for 1 min
before initiation of transport measurements. Reaction medium containing 3H- or 14C-labeled substrate, with or without competing
substrate, was added to initiate the reaction. The concentration of
extravesicular NaCl, KCl, or choline Cl at the start of the measurements was 100 mM, and the internal concentration was zero unless
otherwise stated (osmolarity was adjusted to 300 by including 90 mM
mannitol, 10 mM HEPES, pH 7.4). Reaction times were 10, except for
time course studies. Reactions were stopped by the addition of 1 ml of
an ice-cold stopping solution (145 mM NaCl and 10 mM HEPES, pH
7.4) and the immediate filtering on a 0.45-m Gelman Metricel filter
(Ann Arbor, MI) under vacuum. The filtered membranes were immediately washed four times with 1-ml aliquots of stopping solution,
after which the filters were counted by liquid scintillation spectroscopy. Unless otherwise indicated, all rates were corrected for nonspecific transport, binding, or trapping, as measured in the presence of a
saturating dose of unlabeled substrate.
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Determination of kinetic characteristics. Apparent Km and Vmax
values for lysine were determined by measuring the initial rates of
transport at various concentrations. From these data, a nonlinear
regression analysis was performed using Sigma Plot (SPSS, Chicago,
IL), and apparent Km and Vmax were calculated. The initial rates of
clearance were obtained by dividing the rate of transport of tracer by
the substrate concentrations or by dividing the Vmax by the Km.
Inhibition studies: Ki calculations. In some experiments, AAs or
inhibitors were included in the reaction medium. The velocity with
and without the putative substrates was measured, and the percentage
of inhibition was determined.
Transmembrane potential effect on transport. To create different
initial transmembrane potentials, valinomycin (12.5 g/mg protein), a
K⫹-specific ionophore, was used to increase the permeability of
vesicles to K⫹. Different ratios of internal and external concentrations
of K⫹ were used to establish potential differences ranging from ⫺80.7
to 10.7 mV. The vesicles were prepared overnight with equilibrating
solutions containing 25 or 100 mM KCl, 10 mM HEPES, and
mannitol to bring the final osmolarity to 300 mOsm.
The reaction was initiated by the addition of an appropriate volume
and composition of extravesicular solution to create the desired initial
transmembrane potential as calculated by the Nernst equation.
To measure voltage sensitivity, the equation for a sigmoid curve
was used to fit the data, using Sigma Plot and Microsoft Excel:
a

冉

y⫽

1 ⫹ exp ⫺

冊

x ⫺ xo
k

where a is the maximal initial rate, xo is the midpoint, and k is the
steepness of the curve at the midpoint. Once k was determined, the
effective valence (z) associated with transport was calculated (22):
k⫽

RT
zF

At 37°C, RT/F is 26.7 mV (R is the gas constant, 8.3 J 䡠 K⫺1 䡠 mol⫺1,
T is the temperature in Kelvin, and F is Faraday’s constant, 9.7 ⫻ 104
C/mol).
Protein determination. Protein concentrations were determined
using the Bio-Rad Protein Microassay, with bovine serum albumin as
the standard, on the basis of the method of Bradford (6).
Statistical analyses. Curves were fitted by Sigma Plot and/or
Microsoft Excel, and data were analyzed with StatView (SAS, Cary,
NC) using ANOVA and Fisher’s least significant difference test.
Values were considered significant at P ⬍ 0.05.
RESULTS

Lysine transport is not Na⫹ dependent. To determine
whether Na⫹-dependent CAA transport occurs in BBB membranes, the uptake of lysine was measured in the presence of an
inwardly directed Na⫹ or choline⫹ gradient using a mixedmembrane preparation (both luminal and abluminal membranes). To date, all Na⫹-dependent carriers have been found
only on the abluminal membrane (19). However, by using a
mixed-membrane preparation it was possible to exclude Na⫹
dependency from both membranes in one experiment. The
presence of a Na⫹ gradient did not enhance transport; rather, it
inhibited the rate of uptake (Fig. 1). Because no Na⫹-dependent transport could be detected, mixed membranes were used
for the remaining experiments, except where otherwise indicated.
Lysine transport is not mediated by system b0,⫹. Although
the most common transporter of CAA is system y⫹ (27), other
facilitative systems of CAA have been described. One such
AJP-Endocrinol Metab • VOL

Fig. 1. Lysine uptake in the presence and absence of a Na⫹ gradient. The
uptake of [14C]lysine (30 M) was measured over time in the presence of an
inwardly directed Na⫹ or choline gradient (100 mM external, internal nil).
Mixed membranes (both luminal and abluminal) were used to determine
whether any evidence for Na⫹-dependent transport could be detected. Each
point represents the mean of 3 individual determinations ⫾ SE expressed as
pmol 䡠 mg⫺1 䡠 min⫺1.

system is b0,⫹. It is Na⫹ independent and was originally
described in blastocysts and later shown to be important in
human kidney (17, 27, 34). To explore whether b0,⫹ is active
in the BBB, we measured the uptake of lysine in the presence
of harmaline, a cation that is a particularly strong inhibitor of
system b0,⫹ (54). We detected no significant inhibition of
lysine uptake in the presence of harmaline and, therefore, no
evidence for system b0,⫹ activity (Fig. 2).
Lysine transport is inhibited by homoarginine. System y⫹
activity is identifiable by the use of homoarginine, a CAA (58).
Therefore, we tested the effect of homoarginine on lysine
uptake. Lysine transport was inhibited almost completely in the
presence of either an inwardly directed Na⫹ gradient or a
choline⫹ gradient (Fig. 3). These results support that lysine
transport is mediated by system y⫹.
Kinetics and voltage sensitivity of lysine uptake. The kinetic
characteristics of lysine transport were measured in the presence and absence of a ⫺18.4-mV initial transmembrane potential (Fig. 4). The apparent Km values at 0 and ⫺18 mV were
470 ⫾ 106 and 920 ⫾ 310 M SE (not different statistically,
P ⬎ 0.05), respectively; the corresponding Vmax values were
1.3 ⫾ 0.1 and 2.2 ⫾ 0.3 (SE) nmol䡠mg⫺1 䡠min⫺1. These Km
values are slightly higher than those reported in some cell types
(10, 12, 15), yet they were within the range for isoforms of the
y⫹ transporter reported by others (13). The corresponding
clearance values were 1.9 and 2.4 l䡠mg⫺1 䡠min⫺1, respectively. Although it appeared that the negative transmembrane
potential (⫺18 mV) increased the rate of transport, the results
were not definitive; the Vmax values were statistically significant (P ⬍ 0.05), but the Km values were not. Therefore, the
influence of transmembrane potential was further analyzed by
measuring the initial rate of lysine transport over a range of
transmembrane potentials (Fig. 5). The data (expressed as
pmol䡠mg⫺1 䡠min⫺1) had a maximal rate of 520 ⫾ 60
pmol䡠mg⫺1 䡠min⫺1, the midpoint of the curve was 28 ⫾ 9 mV,
and the slope of the curve at the midpoint was ⫺27 ⫾ 6 mV.
The data indicated that lysine transport was voltage sensitive
and were consistent with one positive charge translocated per
lysine molecule.
Distribution of system y⫹ on the BBB. The distribution of
functional carriers between the luminal and abluminal mem-
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Fig. 2. Lysine uptake is not inhibited by harmaline. Uptake of [14C]lysine (70
M) was measured in the presence and absence of 2 mM harmaline (a potent
inhibitor of the facilitative system b0,⫹) with and without an inwardly directed
Na⫹ or K⫹ gradient (100 mM external, internal nil). (In this instance, K⫹ was
used instead of choline as the control.) Each point represents the mean of 5
individual determinations ⫾ SE expressed as pmol 䡠 mg⫺1 䡠 min⫺1. There were
no statistically significant differences.

brane domains was calculated using an “f value” analysis, as
described by Sánchez del Pino et al. (37). An f value of 1
means that carrier activity is limited to the luminal membrane,
whereas an f value of 0 indicates an abluminal position.
Intermediate numbers describe the relative distribution of active carriers between both membranes. Membranes were separated into five fractions, as described by Sánchez del Pino et
al. (38). The f value associated using data from the purist
fractions 1 (90% pure) and 3 (70% pure) was 0.17 ⫾ 0.04 SE.
Therefore, the location of CAA transport activity was predominantly abluminal, with some activity on the luminal membrane.
Potential substrates of system y⫹ transport. System y⫹ has
been reported to transport some NAA in the presence of Na⫹
(10, 11). Lysine transport was measured in the presence of
alanine and serine (20 mM each), and a range of NaCl concentrations from 0 to 100 mM to determine the optimal
concentration of Na⫹ (Fig. 6). In the absence of NaCl, alanine
and serine did not inhibit lysine uptake significantly. However,

Fig. 3. Lysine uptake is inhibited by homoarginine (HA). HA has been
identified as a potent inhibitor of the y⫹ system (58). Therefore, we tested the
effect of HA on lysine transport. Uptake of [14C]lysine (90 M) was measured
in the presence and absence of HA (20 mM) in the presence of an inwardly
directed choline (Ch) gradient (100 mM external, internal nil). Each point
represents the mean of 5 individual determinations ⫾ SE expressed as
pmol 䡠 mg⫺1 䡠 min⫺1. There were no statistically significant differences found
between any pairs of data.
AJP-Endocrinol Metab • VOL
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Fig. 4. Substrate-velocity curves of lysine at 2 different transmembrane
potentials. [14C]lysine uptake over a range of concentrations (40 M to 3 mM)
and at 2 different transmembrane potentials (0 and ⫺18.4 mV). Transmembrane potentials were calculated by the Nernst equation (MATERIALS AND
METHODS). Each point represents the mean of 5 individual determinations ⫾ SE
expressed as pmol 䡠 mg⫺1 䡠 min⫺1. *Statistical significance (P ⬍ 0.05) compared with their respective control values.

when NaCl was present, lysine uptake was inhibited by both
amino acids in a dose-dependent manner up to 100 mM, the
maximum concentration of NaCl tested.
The uptake of lysine was measured in the presence of
various AAs (2 mM) to determine the potential substrates of
system y⫹ (Table 1). Lysine uptake was inhibited mostly by
the two CAA arginine and ornithine (98 and 80% respectively);
thus the affinity of system y⫹ is arginine ⬎ lysine ⬎ ornithine.
Additionally, several NAA manifested significant inhibition.
However, the Ki values for these essential NAA were 3–10
times greater than the reported plasma concentrations (42, 43).
Therefore, whereas system y⫹ may supplement the activity, the
primary carrier of essential NAA is a Na⫹-independent system
L1 (44). Interestingly, the Ki values for several nonessential
NAA, i.e., serine, glutamine, alanine, and glycine are in the
same range as their plasma concentrations (42).
System y⫹ may supply arginine for NO synthesis in microvessels. NO is synthesized from O2 and arginine, and in
addition to the activity of NOS, the availability of arginine is a

Fig. 5. Uptake of lysine is sensitive to a transmembrane potential. Uptake of
[14C]lysine (30 M) was measured over a range of transmembrane potentials
(⫺80.7 to 10.7 mV). Transmembrane potentials were calculated by the Nernst
equation (MATERIALS AND METHODS). Each point represents 1–3 individual
determinations ⫾ SE expressed as pmol 䡠 mg⫺1 䡠 min⫺1. Maximal initial rate
was 520 ⫾ 60 (SE) pmol 䡠 mg⫺1 䡠 min⫺1, the midpoint of the curve was 28 ⫾
9 mV, and the slope of the curve at the midpoint was ⫺27 ⫾ 6 mV. Effective
valence associated with lysine transport was 1.
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Fig. 6. Determination of the Na⫹ concentration necessary to demonstrate
inhibition of system y⫹ by small neutral amino acids. Uptake of [14C]lysine
(30 M) was measured over a range of Na⫹ concentrations (0 –100 mM) in the
presence of alanine and serine (20 mM each), 2 neutral amino acids that were
reported to inhibit system y⫹ (10, 11). Velocity values were normalized to the
controls (uptake of lysine at each concentration of Na with no inhibitors) and
normalized to a value of 100 ⫾ (SE). *Statistical significance (P ⬍ 0.05)
compared with their respective control values.

determining factor (14, 27). RT-PCR was used to probe two
preparations for mRNA that was specific to the three known
NOS (neuronal, endothelial, and inducible) in microvessels
that were not treated with collagenase IA and microvessels that
were. (Collagenase was used to remove the basement membrane, adhering astrocyte membranes, and pericytes.) The
results indicated that all three forms were expressed at the same
time in the BBB (Fig. 7). Quantitative PCR showed similar
results (data not shown).
Table 1. Amino acid spectrum of system y⫹ in the presence
of Na⫹
Inhibitor

Normalized
Velocity, %

None (NaCl) (9)
Arginine (4)
Ornithine (2)
Cysteine (4)
Serine (5)
Phenylalanine (4)
Glutamine (5)
Histidine (5)
Alanine (5)
Threonine (4)
Valine (4)
Glycine (5)
Methionine (4)
Leucine (5)
Isoleucine (4)
Tyrosine (4)
Proline (5)
Tryptophan (5)
Asparagine (5)

100⫾5
2⫾4
20⫾5
44⫾10
45⫾5
52⫾4
56⫾9
58⫾12
59⫾8
63⫾8
64⫾3
64⫾5
66⫾10
71⫾7
71⫾8
74⫾7
77⫾14
102⫾28
109⫾27

Inhibition, %

Ki, M

98
80
56
55
48
44
42
41
37
36
36
34

34
290
530
540
590
620
630
640
670
680
680
690

Velocity values were normalized to the control velocity and are means ⫾
SE, with the number of determinations in parentheses. Membrane vesicles
were incubated with 73 M [14C]lysine (Km ⫽ 470 M) in the presence of 100
mM NaCl. Inhibition of [14C]lysine transport by several basic and neutral
amino acids (2 mM) was determined. Background was measured in the
presence of 20 mM homoarginine. Percent inhibition and Ki values were
calculated only for those amino acids that were statistically significant (P ⱕ
0.05). Statistical analyses were performed using ANOVA and Fisher’s least
significant difference test for multiple comparisons. See MATERIALS AND
METHODS for the formula to calculate the Ki values.
AJP-Endocrinol Metab • VOL

Fig. 7. mRNA exists in endothelial cells for neuronal nitric oxide synthase
(NOS-1), inducible NOS (NOS-2), and endothelial NOS (NOS-3). Electrophoretic analysis of RT-PCR was performed on a 1.2% agarose gel stained
with ethidium bromide. Total RNA was amplified by RT-PCR using specific
primers (MATERIALS AND METHODS). A: RNA from undigested microvessels. B:
RNA from microvessels that were treated with collagenase IA to remove the
basement membranes, pericytes, and any adhering astrocyte processes.

Membrane proteins from each preparation of microvessels,
collagenase-treated and untreated (20 g protein/lane), were
electrophoresed and immunoblotted with specific antibodies
(Fig. 8). The results corroborated the mRNA data; all three
forms of NOS were expressed with the greatest intensity in the
endothelial cell layer (collagenase digested preparation).
DISCUSSION

As mentioned, plasma membrane CAA transport is carried
out by two families of proteins: Cat, commonly referred to as
the system y⫹; and Bat, which comprises systems b0,⫹, B0,⫹,
and y⫹L (13). These transporters and some of their characteristics are shown in Table 2. In a series of studies employing
enriched luminal and abluminal vesicles, we have shown that
several Na⫹-dependent AA transport systems exist on the
abluminal membrane (29 –31). No Na⫹-dependent systems
have been found on the luminal membrane. There are one or
more Na⫹-dependent systems capable of transporting all nat-

Fig. 8. Western blot analysis of NOS-1, NOS-2, and NOS-3 expression.
Membrane proteins (20 g/lane) were electrophoresed and immunoblotted with specific antibodies (MATERIALS AND METHODS). Lane A was
from collagenase-treated microvessels. Lane B was from untreated microvessels.
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Table 2. Cationic amino acid transport systems
System

Na⫹
Dependence

y⫹

No

b0,⫹
y⫹ L

No
No
Yes

B0,⫹

Yes

Primary Substrates

Lys, Arg, Orn
NAA (weak)
Lys, Arg, Leu
Lys, Arg, Orn
Leu, Met, Gln
other NAA
Lys, Arg, Ala
NAA

Inhibitors

Voltage
Sensitive

homoarginine

Yes

harmaline
N-methylmaleimide

No

BCH

NAA, neutral amino acids; BCH, 2-aminobicyclo(2.2.1)heptane-2-carboxylic acid. Primary references: y⫹ (10); b0⫹ (55); y⫹L (18); B0,⫹ (52).

urally occurring NAA and AAA from the ECF to the endothelial cells (29 –31).
Transporter system B0,⫹ is the only Na⫹-dependent carrier
that carries CAA (as well as NAA, although with less affinity)
and is inhibited by BCH (53). We found no evidence for
system B0,⫹ in the BBB (29). First, the uptake of lysine was
not stimulated by a Na⫹ gradient; rather, uptake in the presence
of a Na⫹ gradient was depressed compared with lysine uptake
in the presence of choline⫹ (Fig. 1). Second, it was previously
shown that the rate of lysine transport was not inhibited by the
presence of concentrations of BCH up to 10 mM (29). The
CAA are unique because all other naturally occurring AAA
and NAA examined to date have Na⫹-dependent transporters
on the abluminal membrane that are capable coupling the Na⫹
gradient existing between the ECF and BBB endothelial cells
to transport AAs out of the ECF (19); facilitative transport
seems to be the only mechanism on the BBB to allow the
movement of CAA. There are three known facilitative transport systems (Na⫹ independent), b0,⫹, y⫹L, and y⫹, that
transport CAA. To obtain a more complete understanding of
CAA transport across the BBB, we determined which of these
transporters are participating in the movement of CAA across
the BBB. 1) System b0,⫹ is a Na⫹-independent AA transporter
discovered in mouse blastocysts (53, 55). System b0,⫹ accepts
CAA as well as bulky NAA that do not branch at the ␤-carbon.
In humans, a defect in expression of b0,⫹ leads to cystinuria
(17, 27, 34). The cation harmaline is a particularly strong
inhibitor of system b0,⫹ (54). We detected no statistically
significant inhibition of lysine uptake (Fig. 2) and, therefore,
no support for the hypothesis that b0,⫹ is active in cerebral
endothelial cells. 2) System y⫹L is a broad-scope AA transporter that was first identified in human erythrocytes (16, 18,
34). System y⫹L has two distinctive properties; it can bind and
translocate CAA as well as NAA, and its specificity varies
depending on the ionic composition of the medium. In a Na⫹
medium it transports a variety of LNAA with a particular
affinity for leucine, isoleucine (27). The data do not support the
hypothesis that y⫹L is active in the BBB. First, lysine transport
in the BBB is voltage sensitive (Fig. 5), whereas system y⫹L
is not (27). Second, leucine, for which y⫹L has a strong
affinity, did not inhibit lysine transport significantly (Table 1).
Third, system y⫹L has a strong affinity for lysine in the low
M range, whereas the affinity in membrane vesicles was 470
M. These observations, together with the demonstration that
homoarginine eliminates lysine transport almost completely
(Fig. 3), leads to the conclusion that system y⫹L is not active,
AJP-Endocrinol Metab • VOL
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or at best could be only a minor component. 3) System y⫹ is a
CAA transport system that carries lysine, arginine and ornithine (10). System y⫹ is voltage sensitive, inhibited by homoarginine and by NAA in the presence of alkali metal ions
Na⫹ ⬎ Li⫹ ⬎ K⫹ (17, 27, 48, 58). In Fig. 3, it is shown that
lysine uptake was inhibited almost completely by homoarginine. Therefore, the majority of observable lysine transport
could be ascribed to system y⫹. Our kinetic data support those
of Stoll et al. (45), who reported that the presence of carrier y⫹
is 40 times higher in cerebral microvessels than whole brain.
Our data show that lysine transport in BBB membranes is
sensitive to the transmembrane potential, which is another
feature of system y⫹ (23). The data were consistent with one
positive charge translocated per lysine molecule. Because Na⫹
does not stimulate transport and lysine has a positive charge at
pH 7, it may be inferred that lysine is drawn into endothelial
cells by the negative transmembrane potential that normally
exists (2). The combined electrical and chemical driving forces
will determine the direction of CAA flux. Assuming cerebral
spinal fluid concentrations of CAA are similar to those of the
ECF (about 10 –30% those in plasma) (42), the net movement
of CAA would occur from plasma to brain.
Although Stoll et al. (45) measured lysine flux from plasma
to brain, y⫹ could only be inferred to exist on both luminal and
abluminal membranes (44). However, with their experimental
technique, no direct measurements of abluminal transport activity could be made to support this assumption. Our data show
that, although lysine transport activity was present on both
membranes, the abluminal membranes had about four times the
activity.
Several nonessential NAA (e.g., serine, glutamine, alanine,
and glycine) inhibited y⫹ transport, presumptive evidence that
small NAA may be transported by system y⫹. Interestingly, the
Ki values were in the same range as the reported plasma
concentrations (42). In a seminal article on BBB permeability,
Oldendorf (32) reported that essential AA uptake was greater
than nonessential AA uptake but did not rule out transport of
nonessential AA. Review of Oldendorf’s data showed some
transport of serine, alanine, proline, and glycine did occur. It
seems likely that these small, nonessential AA enter the brain
at a slow rate on the y⫹ system. Although these small AAs are
not necessary, nor are neurotransmitters (e.g., glycine), Na⫹dependent mechanisms exist on the abluminal membrane that
are capable of returning small NAA to the plasma (29, 31).
Arginine availability is essential for the biosynthesis of the
vasodilator NO, formally known as endothelium-derived relaxing factor because of its ability to relax smooth muscle and
cause vasodilation (35, 56). The synthesis of NO is mediated
by the enzyme NOS that converts arginine and molecular
oxygen to citrulline and NO. Three distinct isoforms of the
enzyme have been identified: Ca2⫹/calmodulin-dependent
NOS-1, NOS-2, and NOS-3. Aside from the distribution of
NOS enzymes, it appears that the astrocyte is the major storage
site for arginine (59), and a neuron-astrocyte shuttle has been
proposed to provide the neuron with arginine (57). Thus the
detection of greater activity of system y⫹ on the abluminal
membrane and the proximity of the astrocytic end feet may
enable rapid equilibration with the ECF and thereby provide
arginine to the astrocytes and neurons. In any event, our
RT-PCR and Western blotting studies revealed that all three
NOS enzymes are present in endothelial cells and suggests that
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the endothelial cell has a significant capacity to produce NO.
However, the function of the NO generated is not clear, as the
endothelial cells of the BBB are not ensheathed with smooth
muscle (5), and thus it is unlikely that NO is mediating changes
in blood flow.
NO may play a role in the maintenance of the BBB (25, 28,
47), communication with astrocytes (8, 24, 49), the control of
ion and nutrient transport (7, 27), and the control of platelet
aggregation (33, 56). The last may explain an observation of
Hernandez et al. (21). They fed monkeys an atherogenic diet
and observed extensive atherosclerosis throughout the body,
with the exception of cerebral vessels. Thus cerebral vessels
appear to be protected, or perhaps the progression of atherosclerotic cerebrovascular disease lags behind that of the rest of
the body.
In conclusion, y⫹ seems to be the primary system for
transporting CAA into the brain. No evidence could be found
for other transporters. In contrast to AAA and NAA, for which
Na⫹-dependent carriers are present on the abluminal membrane, there were no detectable Na⫹-dependent transport systems found for CAA.
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